Article info

Original research
Dual inhibition of BTLA and PD-1 can enhance therapeutic efficacy of paclitaxel on intraperitoneally disseminated tumors

Authors

  • Wei-Zen Sun Department of Anesthesiology, College of Medicine, National Taiwan University, Taipei, Taiwan PubMed articlesGoogle scholar articles
  • Han-Wei Lin Department of Anesthesiology, College of Medicine, National Taiwan University, Taipei, Taiwan PubMed articlesGoogle scholar articles
  • Wan-Yu Chen Graduate Institute of Oncology,College of Medicine, National Taiwan University, Taipei, Taiwan PubMed articlesGoogle scholar articles
  • Chung-Liang Chien Graduate Institute of Anatomy and Cell Biology,College of Medicine, National Taiwan University, Taipei, Taiwan PubMed articlesGoogle scholar articles
  • Yen-Ling Lai Department of Obstetrics and Gynecology,College of Medicine, National Taiwan University, Taipei, TaiwanDepartment of Obstetrics and Gynecology, National Taiwan University Hospital Hsin-Chu Branch, Hsin‑Chu, Taiwan PubMed articlesGoogle scholar articles
  • Jung Chen Department of Obstetrics and Gynecology,College of Medicine, National Taiwan University, Taipei, Taiwan PubMed articlesGoogle scholar articles
  • Yu-Li Chen Department of Obstetrics and Gynecology,College of Medicine, National Taiwan University, Taipei, TaiwanDepartment of Obstetrics and Gynecology, National Taiwan University Hospital Yun-Lin Branch, Yun‑Lin county, Taiwan PubMed articlesGoogle scholar articles
  • Wen-Fang Cheng Graduate Institute of Oncology,College of Medicine, National Taiwan University, Taipei, TaiwanDepartment of Obstetrics and Gynecology,College of Medicine, National Taiwan University, Taipei, TaiwanGraduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Yu-Li Chen; uly1007{at}yahoo.com.tw
View Full Text

Citation

Sun W, Lin H, Chen W, et al
Dual inhibition of BTLA and PD-1 can enhance therapeutic efficacy of paclitaxel on intraperitoneally disseminated tumors

Publication history

  • Accepted June 25, 2023
  • First published July 18, 2023.
Online issue publication 
January 24, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.